rs730882005
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
|
17392385 |
2007 |
rs730882005
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.
|
24493721 |
2014 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.
|
12826609 |
2003 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer.
|
25634208 |
2015 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
|
24590827 |
2014 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer.
|
27179933 |
2016 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
|
8023157 |
1994 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma.
|
20878954 |
2011 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.
|
25504633 |
2015 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan.
|
16337994 |
2006 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients.
|
25691460 |
2015 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
TP53 mutations in older adults with acute myeloid leukemia.
|
26781615 |
2016 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distribution.
|
22866089 |
2011 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing.
|
21115975 |
2011 |
rs730882005
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.
|
20407015 |
2010 |
rs730882005
|
|
T |
0.800 |
GeneticVariation |
CLINVAR |
Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients.
|
11051239 |
2000 |
rs730882005
|
|
T |
0.800 |
GeneticVariation |
CLINVAR |
TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.
|
14673037 |
2003 |
rs730882005
|
|
T |
0.800 |
GeneticVariation |
CLINVAR |
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.
|
21343334 |
2011 |
rs730882005
|
|
T |
0.800 |
GeneticVariation |
CLINVAR |
Functional analysis and molecular modeling show a preserved wild-type activity of p53(C238Y).
|
16818505 |
2006 |